Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IL3-C82E3 | Cynomolgus | Biotinylated Cynomolgus IL-33 Protein, His,Avitag™ |  |
|
|
| IL3-H52H6 | Human | Human IL-33 (C208S, C227S, C232S, C259S) Protein, His Tag (MALS verified) |  |
|
|
| IL3-M82Q7 | Mouse | Biotinylated Mouse IL-33 Protein, His,Avitag™ (MALS verified) |  |
|
|
| IL3-H82H5 | Human | Biotinylated Human IL-33 Protein, His,Avitag™ (MALS verified) |  |
|
|
| IL3-M5245 | Mouse | Mouse IL-33 Protein, His Tag |  |
|
|
| IL3-C5245 | Cynomolgus | Cynomolgus IL-33 Protein, His Tag (MALS verified) |  |
|
|
| IL3-H52H7 | Human | Human IL-33 Protein, His Tag (HPLC verified) |  |
|
|
Loaded Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) on Protein A Biosensor, can bind with Biotinylated Human IL-33, His,Avitag (Cat. No. IL3-H82H5) an affinity constant of 1.81 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Tozorakimab | MEDI-3506 | Phase 3 Clinical | Medimmune | Pneumonia, Viral; Asthma; Diabetic Nephropathies; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic; Bronchitis, Chronic | Details |
| Itepekimab | REGN-3500; SAR-440340 | Phase 3 Clinical | Regeneron Pharmaceuticals Inc, Sanofi | Bronchiectasis; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
| Etokimab | ANB-020 | Phase 2 Clinical | Anaptysbio Inc | Pulmonary Eosinophilia; Sinusitis; Asthma; Peanut Hypersensitivity; Dermatitis, Atopic; Hypersensitivity | Details |
| MT-2990 | MT-2990 | Phase 2 Clinical | Mitsubishi Tanabe Pharma Corp | Rhinitis, Allergic, Seasonal; Pain; Vasculitis; Endometriosis | Details |
| PF-07264660 | PF-07264660 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
| PF-06817024 | PF-06817024 | Phase 1 Clinical | Pfizer Inc | Nasal Polyps; Sinusitis; Dermatitis, Atopic | Details |
| SSGJ-621 | SSGJ-621; 621 | Phase 1 Clinical | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| CAN-10 | CAN-10 | Phase 1 Clinical | Lund University Foundation | Scleroderma, Systemic; Myocarditis; Plaque psoriasis | Details |
| GSK-3862995 | GSK-3862995; GSK3862995; GSK3862995B; GSK-3862995B | Phase 1 Clinical | Glaxosmithkline Plc | Pulmonary Disease, Chronic Obstructive | Details |
| QX-007N | QX-007N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
This web search service is supported by Google Inc.
A-Z
